The Association of Obesity and Liver Enzyme Activities in a Student Population at Increased Risk for Cardiovascular Disease / Veza Između Gojaznosti I Aktivnosti Jetrenih Enzima U Studentskoj Populaciji Sa Povećanim Rizikom Za Nastanak Kardiovaskularnih Bolesti

Open access

Summary

Background: It has been reported that obesity is associated with metabolic syndrome, insulin resistance, cardiovascular risk but also with nonalcoholic fatty liver disease (NAFLD). The prevalence of obesity in children and adolescents is increasing rapidly all over the world. The aim of this study was to analyze the value of liver enzymes: AST, ALT and γGT in a group of obese students in order to establish their correlation to anthropometric parameters such as: BMI (body mass index), WC (waist circumference), HC (hip circumference), and WHR (waist-to-hip ratio) compared to non-obese students who comprised the control group (CG).

Methods: In this study, 238 students from the University of Novi Sad of both sexes (126 men and 112 women) with a mean age of 22.32 ± 1.85 years were included. According to the body mass index (BMI) lower and higher than 25 kg/m2 and waist circumference (WC) lower and higher than 94 cm (80 cm for females) the whole group of 238 students was divided into 2 subgroups: the obese group at increased risk for CVD (Group 1) and the group at lower risk for CVD (Group 2). AST, ALT and γGT activities were determined in fasting blood samples.

Results: Statistical processing data revealed significantly higher values of AST, ALT and γGT in the group of students with BMI>25 kg/m2, WC>94 cm for males and WC>80 cm for females, HC>108 cm for males and HC>111 cm for females, and WHR>0.90 for males and WHR>0.80 for females (P<0.001). Significant association was established between anthropometric parameters and liver enzyme levels (P<0.0001).

Conclusions: Obese students with higher BMI, WC, HC and WHR values have higher liver enzyme activites and a higher chance to develop NAFLD in the future.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Ho TF. Cardiovascular risk associated with obesity in children and adolescents. Ann Acad Med Singapore 2009; 38: 48-56.

  • 2. Lobstein T Baur L Uauy R. Obesity in children and young people: a crisis in public health. Obes Rev 2004; S1: 4-85.

  • 3. Krauss RM Winston M Fletcher BJ Grundy SM. Obesity: impact on cardiovascular disease. Circulation 1998; 98: 1472-6.

  • 4. Colditz GA Willett WC Rotnizky A Manson JE. Weight gain a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481-6.

  • 5. Veigas NM Dharmalingam M Rani Marcus S. Oxidative stress in obesity and metabolic syndrome in Asian Indians. Journal of Medical Biochemistry 2011; 30: 115-20.

  • 6. Aslan D. Biomarkers for diabetes complications: the results of several clinical studies. Journal of Medical Biochemistry 2011; 30: 207-12.

  • 7. Ali AA Phalisteen S El-Napolis M Fahmy MA. Lipoprotein metabolism abnormalities in patients with chronic renal insufficiency. Journal of Medical Biochemistry 2011; 30: 38-44.

  • 8. Dimitrijević-Srećković V Čolak E Đorđević P Gostiljac D Srećković B Popović S et al. Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome. Clin Chem Lab Med 2007; 45(9): 40-4.

  • 9. Kelishadi R Cook SR Adibi A Faghihimani Z Ghatrehsamani S Beihaghi A et al. Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normal-weight overweight and obese children and adolescents. Diabetology and Metabolic Syndrome 2009; 1: 29.

  • 10. Chan DF Li AM Chu WC Chan MH Wong EM Liu EK et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004; 28: 1257-63.

  • 11. Roberts EA. Non-alcoholic fatty liver disease (NAFLD) in children. Front Biosci 2005; 10: 2306-18.

  • 12. Franzese A Vajro P Argenziano A Puzziello A Iannucci MP Saviano MC et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997; 42: 1428-32.

  • 13. Oliveira AC Oliveira AM Almeida MS Silva AM Adan L Ladela AM. Alanine aminotransferase and high-sensitive C-reactive protein correlates of cardiovascular risk factors in youth. J Pediatr 2008; 152: 337-42.

  • 14. Taylor RW Jones IE Williams SM Goulding A. Evaluation of waist circumference waist-to-hip ratio and conicity index as screening tools for high trunk fat mass as measured by dual-energy X-ray absorptiometry in children aged 3-9y. Am J Clin Nutr 2000; 72: 490-5.

  • 15. Katzmarzyk PT Srinivasan SR Chen W Mallina RM Bouchard C Berenson GS. Body mass index waist circumference and clustering of cardiovascular disease risk factors in a biracial sample of children and adolescents. Pediatrics 2004; 114: 198-205.

  • 16. Moreno LA Pineda I Rodriguez G Fleta J Sarria A Bueno M. Waist circumference for the screening of the metabolic syndrome in children. Acta Pediatr 2002; 91: 1307-12.

  • 17. Petrović D Obrenović R Trbojević-Stanković J Majkić-Singh N Stojimirović B. Cardiovascular mortality in hemodialysis patients: Clinical and epidemiological analysis. Journal of Medical Biochemistry 2011; 30: 302-8.

  • 18. Bajčetić M Brajović M Korkut-Tešić R. Diagnostic and therapeutic significance of the oxidative stress parame- ters in children. Journal of Medical Biochemistry 2010; 29: 196-203.

  • 19. Ciba I Widhalm K. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents. Acta Pediatr 2007; 96: 109-12.

  • 20. Quiros-Tejeira RE Rivera CA Ziba TT Mehta N Smith CW Butte NF Risk for non-alcoholic fatty liver disease in Hispanic youth with BMI > or = 95th percentile. J Pediatr Gastroenterol Nutr 2007; 44: 228-36.

  • 21. Samocha-Bonet D Chisol DJ Tonks K Campbell LV Greenfield JR. Insulin-sensitive obesity in humans - a »favorable fat« phenotype? Trends in Endocrinology and Metabolism 2012; 23: 116-24.

  • 22. Đerić M Čabarkapa VS. Cardiovascular biomarkers in chronic kidney disease. Journal of Medical Biochemistry 2010; 29: 298-303.

  • 23. Shovakumar N Kumar MJ Aswathanarayan MN Venkatesh MS Sheshadri M Deshmukh S et al. Role of retinol-binding protein 4 in obese Asian Indians with metabolic syndrome. Journal of Medical Biochemistry 2012; 31(1): 40-6.

  • 24. Manolio TA Savage PJ Burke GL Liu KA Wagenknecht LE Sidney S et al. Association of fasting insulin with blood pressure and lipids in young adults: the CARDIA study. Atherosclerosis 1990; 10: 430-6.

  • 25. Klein S Burke LE Bray GA Blair S Allison DB Pi-Sunyer X et al. American Heart Association Council on Nutrition Physical Activity and Metabolism. Clinical interpretation of obesity with specific focus on cardiovascular disea se: a statement for professionals from the American Heart Association Council on Nutrition Physical Activity and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2004; 110: 2952-67.

  • 26. Drukteinis JS Roman MJ Fabsitz RR Lee ET Best LG Rusell M et al. Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults: The Strong Heart Study. Circulation 2007; 115: 221-7.

  • 27. Baker JL Olsen LW Sorensen TI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007; 357: 2329-37.

Search
Journal information
Impact Factor

IMPACT FACTOR 2018: 2.000
5-year IMPACT FACTOR: 1.075

CiteScore 2018: 1.47

SCImago Journal Rank (SJR) 2018: 0.523
Source Normalized Impact per Paper (SNIP) 2018: 0.581

Cited By
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 237 117 7
PDF Downloads 123 54 3